Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold.
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold.
复制标题
DOI:
10.1016/j.jtbi.2022.111063
复制
发表时间:
2022-05-07
影响因子:
2
通讯作者:
Aguas R
中科院分区:
文献类型:
--
作者:
Gomes MGM;Ferreira MU;Corder RM;King JG;Souto-Maior C;Penha-Gonçalves C;Gonçalves G;Chikina M;Pegden W;Aguas R
Individual variation in susceptibility and exposure is subject to selection by natural infection, accelerating the acquisition of immunity, and reducing herd immunity thresholds and epidemic final sizes. This is a manifestation of a wider population phenomenon known as “frailty variation”. Despite theoretical understanding, public health policies continue to be guided by mathematical models that leave out considerable variation and as a result inflate projected disease burdens and overestimate the impact of interventions. Here we focus on trajectories of the coronavirus disease (COVID-19) pandemic in England and Scotland until November 2021. We fit models to series of daily deaths and infer relevant epidemiological parameters, including coefficients of variation and effects of non-pharmaceutical interventions which we find in agreement with independent empirical estimates based on contact surveys. Our estimates are robust to whether the analysed data series encompass one or two pandemic waves and enable projections compatible with subsequent dynamics. We conclude that vaccination programmes may have contributed modestly to the acquisition of herd immunity in populations with high levels of pre-existing naturally acquired immunity, while being crucial to protect vulnerable individuals from severe outcomes as the virus becomes endemic.
登录
查看更多内容
DOI:
10.1126/science.abg3055
发表时间:
2021-04-09
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Davies NG;Abbott S;Barnard RC;Jarvis CI;Kucharski AJ;Munday JD;Pearson CAB;Russell TW;Tully DC;Washburne AD;Wenseleers T;Gimma A;Waites W;Wong KLM;van Zandvoort K;Silverman JD;CMMID COVID-19 Working Group;COVID-19 Genomics UK (COG-UK) Consortium;Diaz-Ordaz K;Keogh R;Eggo RM;Funk S;Jit M;Atkins KE;Edmunds WJ
通讯作者:
Edmunds WJ
影响因子:
4.3
作者:
Chen S;Flegg JA;White LJ;Aguas R
通讯作者:
Aguas R
影响因子:
5
作者:
Dodd PJ;Looker C;Plumb ID;Bond V;Schaap A;Shanaube K;Muyoyeta M;Vynnycky E;Godfrey-Faussett P;Corbett EL;Beyers N;Ayles H;White RG
通讯作者:
White RG
影响因子:
1.9
作者:
GART, JJ
通讯作者:
GART, JJ
DOI:
10.1126/science.abn8347
发表时间:
2022-03-25
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Elliott P;Bodinier B;Eales O;Wang H;Haw D;Elliott J;Whitaker M;Jonnerby J;Tang D;Walters CE;Atchison C;Diggle PJ;Page AJ;Trotter AJ;Ashby D;Barclay W;Taylor G;Ward H;Darzi A;Cooke GS;Chadeau-Hyam M;Donnelly CA
通讯作者:
Donnelly CA